Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Study of the Bard® LifeStent® Solo Vascular Stent System (REALITY2)

NCT02262949 is registered in ClinicalTrials.gov with C. R. Bard as lead sponsor.

NCT NCT02262949
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02262949 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Study of the Bard® LifeStent® Solo Vascular Stent System (REALITY2)
Lead sponsor
C. R. Bard
Phase
Not applicable
Overall status
Completed
Start date
September 30, 2014
Completion date
July 31, 2016
Enrollment
31 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

peripheral artery disease